IDEXX LABORATORIES INC /DE Number of Operating Segments
IDEXX LABORATORIES INC /DE (IDXX) reported Number of Operating Segments of 3 segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfOperatingSegments · last filed 2026-08-04
- IDEXX LABORATORIES INC /DE number of operating segments for the quarter ending 2026-03-31 was 3.00 segment, a 0.00% change year-over-year.
- IDEXX LABORATORIES INC /DE number of operating segments for the quarter ending 2025-03-31 was 3.00 segment.
- IDEXX LABORATORIES INC /DE number of operating segments for fiscal 2025 was 3.00 segment, a 0.00% change from fiscal 2024.
- IDEXX LABORATORIES INC /DE number of operating segments for fiscal 2024 was 3.00 segment.
| Period end | Number of Operating Segments 3 month | Number of Operating Segments 6 month | Number of Operating Segments 9 month | Number of Operating Segments 12 month |
|---|---|---|---|---|
| 2026-06-30 | 3.00 segment 10-Q · filed 2026-08-04 | |||
| 2026-03-31 | 3.00 segment 10-Q · filed 2026-05-05 | |||
| 2025-12-31 | 3.00 segment 10-K · filed 2026-02-20 | |||
| 2025-09-30 | 3.00 segment 10-Q · filed 2025-11-03 | |||
| 2025-06-30 | 3.00 segment 10-Q · filed 2025-08-04 | |||
| 2025-03-31 | 3.00 segment 10-Q · filed 2025-05-01 | |||
| 2024-12-31 | 3.00 segment 10-K · filed 2025-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |